A detailed history of Pettyjohn, Wood & White, Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pettyjohn, Wood & White, Inc holds 889 shares of VRTX stock, worth $412,993. This represents 0.08% of its overall portfolio holdings.

Number of Shares
889
Previous 889 -0.0%
Holding current value
$412,993
Previous $416,000 0.72%
% of portfolio
0.08%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $19,640 - $24,276
50 Added 5.96%
889 $416,000
Q1 2024

May 08, 2024

SELL
$407.69 - $446.08 $11,415 - $12,490
-28 Reduced 3.23%
839 $350,000
Q2 2023

Aug 10, 2023

SELL
$314.42 - $351.91 $7,231 - $8,093
-23 Reduced 2.58%
867 $305,000
Q2 2022

Aug 08, 2022

BUY
$234.96 - $292.55 $209,114 - $260,369
890 New
890 $251,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pettyjohn, Wood & White, Inc Portfolio

Follow Pettyjohn, Wood & White, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pettyjohn, Wood & White, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pettyjohn, Wood & White, Inc with notifications on news.